Lynn Farner, Tim M. Emmenegger, Simon Schading-Sassenhausen, Julia Berroth, Maryam Seif, Armin Curt, Patrick Freund, The Nogo Inhibition in Spinal Cord Injury Study Group
{"title":"3D MRI Tract-Specific Spinal Cord Lesion Pattern Improves Prediction of Distinct Neurological Recovery","authors":"Lynn Farner, Tim M. Emmenegger, Simon Schading-Sassenhausen, Julia Berroth, Maryam Seif, Armin Curt, Patrick Freund, The Nogo Inhibition in Spinal Cord Injury Study Group","doi":"10.1002/acn3.70087","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>To distinguish lateralized motor- and sensory-tract damage after acute spinal cord injury (SCI) and explore its predictive power for motor and sensory recovery.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Thirty-five SCI patients (two female) from a multi-center data set (placebo-arm of the Nogo-A-Inhibition in SCI trial) underwent routine T2-weighted sagittal MRI scans at the lesion site at baseline (19.9 days, 95% confidence interval [CI]: 17.9–21.8), 1-month (54.2 days, 95% CI: 52.1–56.2), and 6-month (192.4 days, 95% CI: 181.3–203.6) post-injury. Concurrently with the MRI scans, clinical examinations were performed. Lesions were manually segmented across all slices, and 3D-tract damage was assessed by determining the overlap between segmented lesions and identified motor and sensory tracts in the axial plane. The relationship between lesion assessments and baseline-adjusted clinical outcomes at 6 months was explored.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Over the 6-month, patients recovered by 4.95 motor points/month (95% CI: 3.89–5.89, <i>p</i> < 0.001) on the International Standards for the Neurological Classification of SCI scale, 2.28 light-touch points/month (95% CI: 1.43–3.12, <i>p</i> < 0.001), and 2.06 pinprick points/month (95% CI: 1.21–2.91, <i>p</i> < 0.001). Lesion volume decreased from 381.82mm <sup>3</sup> (95% CI: 295.78–467.87) by −14.04 mm<sup>3</sup>/month (95% CI: −25.39 to −1.56, <i>p</i> = 0.023). MRI visible changes in motor tract damage over the 6-month were marginal (0.02%/month, 95% CI: −0.81 to −1.02, <i>p</i> = 0.971). Changes in the sensory tracts were more pronounced, decreasing by −0.69%/month (95% CI: −1.29 to −0.09, <i>p</i> = 0.05). Left-and-right motor-tract damage at baseline significantly predicted left-and-right motor score recovery (<i>R</i><sup>2</sup> = 0.75, <i>p</i> = 0.015), while baseline left-and-right sensory-tract damage significantly predicted improvements in left-and-right pin-prick scores (<i>R</i><sup>2</sup> = 0.79, <i>p</i> = 0.024).</p>\n </section>\n \n <section>\n \n <h3> Interpretation</h3>\n \n <p>Revealing the extent of damage to spinal motor-and sensory-pathways early after SCI is a valuable predictor of related neurological recovery. Tracking 3D dynamics of major spinal pathways has the potential to enhance diagnostic accuracy and patient stratification for future clinical trials.</p>\n </section>\n </div>","PeriodicalId":126,"journal":{"name":"Annals of Clinical and Translational Neurology","volume":"12 9","pages":"1762-1770"},"PeriodicalIF":3.9000,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/acn3.70087","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Clinical and Translational Neurology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/acn3.70087","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To distinguish lateralized motor- and sensory-tract damage after acute spinal cord injury (SCI) and explore its predictive power for motor and sensory recovery.
Methods
Thirty-five SCI patients (two female) from a multi-center data set (placebo-arm of the Nogo-A-Inhibition in SCI trial) underwent routine T2-weighted sagittal MRI scans at the lesion site at baseline (19.9 days, 95% confidence interval [CI]: 17.9–21.8), 1-month (54.2 days, 95% CI: 52.1–56.2), and 6-month (192.4 days, 95% CI: 181.3–203.6) post-injury. Concurrently with the MRI scans, clinical examinations were performed. Lesions were manually segmented across all slices, and 3D-tract damage was assessed by determining the overlap between segmented lesions and identified motor and sensory tracts in the axial plane. The relationship between lesion assessments and baseline-adjusted clinical outcomes at 6 months was explored.
Results
Over the 6-month, patients recovered by 4.95 motor points/month (95% CI: 3.89–5.89, p < 0.001) on the International Standards for the Neurological Classification of SCI scale, 2.28 light-touch points/month (95% CI: 1.43–3.12, p < 0.001), and 2.06 pinprick points/month (95% CI: 1.21–2.91, p < 0.001). Lesion volume decreased from 381.82mm 3 (95% CI: 295.78–467.87) by −14.04 mm3/month (95% CI: −25.39 to −1.56, p = 0.023). MRI visible changes in motor tract damage over the 6-month were marginal (0.02%/month, 95% CI: −0.81 to −1.02, p = 0.971). Changes in the sensory tracts were more pronounced, decreasing by −0.69%/month (95% CI: −1.29 to −0.09, p = 0.05). Left-and-right motor-tract damage at baseline significantly predicted left-and-right motor score recovery (R2 = 0.75, p = 0.015), while baseline left-and-right sensory-tract damage significantly predicted improvements in left-and-right pin-prick scores (R2 = 0.79, p = 0.024).
Interpretation
Revealing the extent of damage to spinal motor-and sensory-pathways early after SCI is a valuable predictor of related neurological recovery. Tracking 3D dynamics of major spinal pathways has the potential to enhance diagnostic accuracy and patient stratification for future clinical trials.
期刊介绍:
Annals of Clinical and Translational Neurology is a peer-reviewed journal for rapid dissemination of high-quality research related to all areas of neurology. The journal publishes original research and scholarly reviews focused on the mechanisms and treatments of diseases of the nervous system; high-impact topics in neurologic education; and other topics of interest to the clinical neuroscience community.